Resting energy requirement in early phase of acute pancreatitis as a prognostic criterion of the course of disease

Author(s):  
O.G. Sivkov ◽  
A.O. Sivkov
2020 ◽  
Vol 21 (3) ◽  
pp. 83-86
Author(s):  
O. G. Sivkov ◽  
◽  
A. O. Sivkov ◽  
◽  

Purpose. To investigate the features of resting energy expenditure and urinary nitrogen excretion during stress-induced hyperglycemia at an early phase of acute severe pancreatitis. Materials and methods. The study design was a prospective single-center cohort study. The inclusion criteria were: diagnosed acute pancreatitis and at least one severity predictor. On day one, three, and five the dark blood glycemic index and urinary nitrogen excretion were measured and resting energy expenditure was determined in all patients. From the total number of cases (n = 72), a cohort of patients with severe acute pancreatitis was singled out (n = 23). In that cohort, three groups were formed. The first group included measurements made over the whole observation period (n = 69), the second – normoglycemia (n = 48), and the third one – hyperglycemia. Stress-induced hyperglycemia was determined as increased blood glucose ≥ 11.1 mmol/L. The raw data were statistically processed using SPSS package. The zero hypothesis was rejected at p < 0.05. Results. A statistically significant difference was found between the second and third groups in the glycemia index (p < 0.001) and urinary nitrogen excretion (p = 0.022), but not in the resting energy expenditure (p = 0.157). The prevalence of glycemia among the deceased amounted to 66.6% and among the survived – 17.2%. To make up the quantity of nitrogen lost with urine, the normoglycemia patients required an uptake of 117.1 nonprotein kcal per 1 g of nitrogen, and the hyperglycemia patients -61.7 kcal. Conclusion. At an early phase of acute severe pancreatitis, urinary nitrogen excretion rises in a statistically significant manner in patients with stress-induced hyperglycemia. To make up the urinary nitrogen loss, the normoglycemia patients require 117.1 nonprotein kcal per 1 g of nitrogen while hyperglycemia patients – 61.7.


Pancreatology ◽  
2021 ◽  
Vol 21 ◽  
pp. S30
Author(s):  
I. Luiken ◽  
S. Eisenmann ◽  
J. Garbe ◽  
J. Dober ◽  
W.A. Wohlgemuth ◽  
...  

Pancreas ◽  
2010 ◽  
Vol 39 (7) ◽  
pp. 1077-1081
Author(s):  
Benoy Idicula Babu ◽  
Ajith K. Siriwardena

Pancreatology ◽  
2004 ◽  
Vol 4 (3-4) ◽  
pp. 233-243 ◽  
Author(s):  
Wen-Kui Yu ◽  
Wei-Qin Li ◽  
Ning Li ◽  
Jie-Shou Li

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Xuefeng Cao ◽  
Xixiu Wang ◽  
Xiaoliang Xu ◽  
Yanmin Lu ◽  
Baolei Zhao ◽  
...  

Background. Periampullary tumors (PT) may rarely present as acute pancreatitis (AP) or acute recurrent pancreatitis (ARP). Unlike other cases of AP and ARP, these conditions necessitate pancreaticoduodenectomy (PD), and timely diagnosis is crucial. Materials and Methods. A retrospective review of clinical, radiological, surgical, and pathological data was conducted for patients admitted to the Binzhou Medical University Hospital during the period from January 2010 to December 2017, for AP or ARP caused by PT. All patients included in the study group had undergone PD. The perioperative data for these patients was compared with data for patients with PT but without AP or ARP who underwent PD during the same period (control group). Results. During the study period, 412 patients with AP or ARP were treated; among this group, 15 patients had PT. Compared with controls, patients in the study group were younger in age and had a longer course of disease, more frequent hospitalizations, and more severe derangements in laboratory data (P<0.05). Operative time and intraoperative blood loss were significantly higher in the study group, but the incidence of postoperative outcomes such as pancreatic/biliary fistula, abdominal infection, postoperative hospital stay, and mortality were similar between groups (P>0.05). Conclusions. Neither AP nor ARP has any adverse impact on the outcomes of PD. However, in the treatment of younger patients suffering from AP or ARP, unexplained pancreatic duct dilation and weight loss should raise the suspicion of PT. EUS and EUS-FNA may be helpful in making the diagnosis.


1995 ◽  
Vol 30 (2) ◽  
pp. 186-191 ◽  
Author(s):  
J. E. Dominguez-Munoz ◽  
O. Pieramico ◽  
M. Buchler ◽  
P. Malfertheiner

Pancreatology ◽  
2015 ◽  
Vol 15 (3) ◽  
pp. S9
Author(s):  
Violeta García-Hernández ◽  
Domitille Schvartz ◽  
Carmen Sánchez-Bernal ◽  
José Julián Calvo ◽  
Jean-Charles Sanchez ◽  
...  

1989 ◽  
Vol 76 (8) ◽  
pp. 878-879 ◽  
Author(s):  
P.-A. Clavien ◽  
H. Hauser ◽  
P. Meyer ◽  
A. Rohner ◽  
N. J. M. London ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document